GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Pre-Tax Income

Celadon Pharmaceuticals (LSE:CEL) Pre-Tax Income : €-8.75 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Celadon Pharmaceuticals's pretax income for the six months ended in Dec. 2023 was €-3.58 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-8.75 Mil. Celadon Pharmaceuticals's pretax margin was -4,594.87%.

During the past 5 years, Celadon Pharmaceuticals's highest Pretax Margin was -10036.78%. The lowest was -282200.00%. And the median was -74400.00%.

Celadon Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Celadon Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Pre-Tax Income Chart

Celadon Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
- -1.17 -5.64 -20.83 -8.73

Celadon Pharmaceuticals Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial -3.35 -15.68 -5.36 -5.17 -3.58

Competitive Comparison of Celadon Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celadon Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's Pre-Tax Income falls into.


Celadon Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Celadon Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-7.215+0+-0.694+0.037+-0.86
=-8.73

Celadon Pharmaceuticals's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.027+0+-0.349+0.007+-0.215
=-3.58

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-8.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celadon Pharmaceuticals  (LSE:CEL) Pre-Tax Income Explanation

Celadon Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-3.584/0.078
=-4,594.87%

During the past 5 years, Celadon Pharmaceuticals's highest Pretax Margin was -10036.78%. The lowest was -282200.00%. And the median was -74400.00%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celadon Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Pre-Tax Income
Comparable Companies
LSE:STX LSE:AGY LSE:EAH LSE:VLG LSE:CHLL LSE:PXS LSE:ANCR AQSE:ANA LSE:HELD LSE:N4P ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
32-33 Cowcross Street, London, GBR, EC1M 6DF
Website
https://www.celadonpharma.co.uk
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines